Cathepsin-D (CATH-D) is a lysosomal protease induced by estrogens in estrogen receptor-positive breast cancer cell lines and constitutively produced by estrogen receptor-negative breast cancer cells. The concentration of CATH-D in the cytosol of 97 human breast tumor tissues was correlated with other well-known prognostic factors for human breast cancer. CATH-D was significantly higher in node-positive than in node-negative tumors (P = 0.042, Kruskal-Wallis test). However, no correlation was found between enzyme levels and the number of positive nodes. CATH-D concentration did not correlate with age, menopausal status, clinical stage of the disease, size of the primary tumor, steroid receptors, thymidine labeling index, histological grade, nuclear grade or cellularity. CATH-D did not show any association with the known prognostic factors evaluated in this study and its association with lymph nodes was only weak.
Alexieva-FiguschJ., Van PuttenW.L.J., BlankensteinM.A., Blonk-Van Der WijstJ., KlijnJ.G.M.: The prognostic value and relationships of patient characteristics, estrogen and progestin receptors and site of relapse in primary breast cancer. Cancer, 61: 758โ768, 1988.
2.
BradfordM.M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochem., 72: 248โ254, 1976.
3.
CazinJ.L., GosselinP., BonifaceB., BonifaceM., DemailleA.: Expression of pS2 and cathepsin D in breast cancer. Int. J. Oncol., 2: 1081โ1084, 1993.
4.
ClarkG.M., Mc GuireW.L., HubayC.A., PearsonO.H., MarshallJ.S.: Progesterone receptors as a prognostic factor in stage II breast cancer. N. Engl. J. Med., 309: 1343โ1347, 1983.
5.
DuffyM.J., BroilletJ-P., ReillyD., Mc DermottE., O'HigginsN., FennellyJ., MaudelondeT., RochefortH.: Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological and clinical findings. Clin. Chem., 37: 101โ104, 1991.
6.
EdwardsD.D.P., ChamnessG.C., Mc GuireW.L.: Estrogen and progesteron receptors in breast cancer. Biochim. Biophys. Acta, 560: 457โ486, 1979.
7.
FoekensJ.A., Van PuttenW.L.J., PortengenH., KoningH.Y.W.C.M., ThirionB., Alexieva-FiguschJ., KlijnJ.G.M.: Prognostic value of pS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis. J. Clin. Oncol., 11: 899โ908, 1993.
8.
GionM., MioneR., DittadiR., RomanelliM., PappagalloL., CapitanioG., FriedeU., BarbazzaR., VisonaA., DanteS.: Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer. Eur. J. Cancer, 31A: 671โ677, 1995.
9.
GlikmanP., VeghI., PollinaM.A., MostoA.H., LevyC.M.: Ornythine decarboxylase activity, prolactin blood levels and estradiol and progesterone receptors in human breast cancer. Cancer, 60: 2237โ2243, 1987.
10.
GranataG., CoradiniD., CappellettiV., Di FronzoG.: Prognostic relevance of cathepsin-D versus oestrogen receptors in node negative breast cancer. Eur. J. Cancer, 27: 970โ972, 1991.
11.
HorwitzK.B., McGuireW.L., PearsonO.H., SegaloffA.: Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science, 189: 726โ727, 1975.
12.
HorwitzK.B., WeiL.L., SeedlacekS.M., D'ArveilleC.N.: Progestin action and progesterone receptor structure in human breast cancer: a review. Recent Prog. Horm. Res., 41: 249โ316, 1985.
13.
KnightW.A., LivingstonR.B., GregoryE.J., Mc GuireW.L.: Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res., 37: 4669โ4671, 1977.
14.
LettoG., GebbiaN., RamaL., TumminelloF.M.: Cathepsin D in the malignant progression of neoplastic disease (review). Anticancer Res., 12: 235โ240, 1992.
15.
MarsiglianteS., BiscozzoL., GrecoS., LeoG., StorelliC.: Relation of cathepsin D level to the estrogen receptor in human breast cancer. Int. J. Clin. Lab. Res., 22: 52โ57, 1992.
16.
MaudelondeT., KhalafS., GarciaM., FreissG., DuporteJ., BenatiaM., RogierH., PaolucciF., SimonyJ., PujolH., PauB., RochefortH.: Immunoenzymatic assay of Mr 52, 000 cathepsin-D in 182 breast cancer cytosols. Low correlation with other prognostic parameters. Cancer Res., 48: 462โ466, 1988.
17.
Mc GuireW.L., De La GarzaM., ChamnesG.C.: Evaluation of estrogen receptor assays in human breast cancer tissue. Cancer Res., 37: 637โ639, 1977.
18.
MontcourrierP., MangeatP.H., SalazarG., MorissetM., SahuquetA., RochefortH.: Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res., 50: 6045โ6054, 1990.
19.
NamerM., RamaioliA., FontanaX., EtienneM.C., HeryM., JourlaitA., MilanoG., FrenayM., FrancoisE., LapalusF.: Prognostic value of total cathepsin-D in breast tumors. A possible role in selection of chemoresistant patients. Breast Cancer Res. Treat.19: 85โ93, 1991.
20.
PichonM.F., MilgromE.: Characterization and assay of progesterone receptor in human mammary carcinoma. Cancer Res., 37: 464โ471, 1977.
21.
PujolP., MaudelondeT., DauresJ-P., RouanetP., BrouilletJ-P., PujolH., RochefortH.: A perspective study of the prognostic value of cathepsin D levels in breast cancer cytosol. Cancer, 71: 2006โ2012, 1993.
22.
RochefortH., CaponyF., GarciaM., CavaillesV., FreissG., ChambonM., MorissetM., VignonF.: Estrogen-induced lysosomal proteases secreted by breast cancer cells: a role in carcinogenesis? J. Cell. Biochem., 35: 17โ29, 1987.
23.
RochefortH., AugereauP., BriozzoP., CaponyF., CavaillesV., FreissG., GarciaM., MaudelondeT., MorissetM., VignonF.: Structure, function, regulation and clinical significance of the 52 K pro-cathepsin D secreted by breast cancer cells. Biochimie, 70: 943โ949, 1988.
24.
RochefortH.: Biological and clinical significance of Cathepsin-D in breast cancer. Acta Oncol., 31: 125โ130, 1992.
25.
RochefortH.: Cathepsin-D in breast cancer; a tissue marker associated with metastasis. Eur. J. Cancer, 28A: 1780โ1783, 1992.
26.
RomainS., MuraccioleX., VaretteI., BressacC., BrandoneH., MartinP.M.: La cathepsine-D: un facteur pronostique independant dans la cancer du sein. Bull. Cancer, 77: 439โ447, 1990.
27.
SchultzD.C., ShamidehB., WrightL.M., TuckerS., LangeM.K., TachevskyT., LongoS., NiedbaalaS., AlhadeffJ.A.: Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls. Cancer Res., 54: 48โ54, 1994.
28.
ShaheenR.M., MiseljicS., WhieleR.D., WittliffJ.L.Relation between cathepsin D expression and other prognostic factors in breast carcinomas. Clin. Chem., 41: 1585โ1591, 1995.
29.
SilvestriniR., DaidoneM.G., ValagusaP., SalvadoriB., RoviniD., BonadonnaG.: Cell kinetics as a prognostic marker in locally advanced breast cancer. Cancer Treat. Rep., 71: 375โ379, 1987.
30.
SpyratosF., BrouilletJ-P., De FrenneA., HaceneK., RouesseJ., MaudelondeT., BrunetM., AndridC., DesplacesA., RochefortH.: Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet, I: 1115โ1118, 1989.
31.
TandonA.K., ClarkJ.M., ChamnessG.C., ChirgwinJ.M., Mc GuireW.L.: Cathepsin D and prognosis in breast cancer. N. Engl. J. Med., 332: 297โ302, 1990.
32.
ThorpeS., RochefortH., GarciaM., FreissG., ChristensenI.J., KhalafS., PaolucciF., PauB., RasmussenB.B., RoseC.Association between high concentration of Mr 52, 000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res., 49: 6008โ6014, 1989.
33.
TubianaM., PejovicM., ChavandraN.: The long term prognostic significance of the thymidine labeling index on breast cancer. Int. J. Cancer, 33: 441โ445, 1985.
34.
WestleyB.R., RochefortH.: A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell, 20: 353โ362, 1980.
35.
WestleyB.R., MayF.E.B.: Oestrogen regulates cathepsin D mRNA levels in estrogen responsive human breast cancer cells. Nucleic Acids Res., 15: 3773โ3786, 1987.
